Document is current
Any future updates will be listed below
-
Authors
Blobner, Jens
Ruf, Viktoria
Weller, Jonathan
Teske, Nico
Forbrig, Robert
Thon, Niklas
Albert, Nathalie L.
von Baumgarten, Louisa
Schoenecker, Stephan
Tonn, Joerg-Christian
Ringel, Florian
Harter, Patrick N.
Karschnia, Philipp
-
Funding
Funding for this research was provided by:
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 24 April 2025
Accepted: 14 July 2025
First Online: 23 July 2025
Declarations
:
: The authors declare no competing interests.
: Jens Blobner: No disclosures. Viktoria Ruf: No disclosures. Jonathan Weller: No disclosures. Nico Teske: No disclosures. Robert Forbrig: No disclosures. Niklas Thon: No disclosures. Nathalie L. Albert has received honoraria for lectures, consultation or advisory board participation from ABX, Advanced Accelerator Applications, Carthera, ITM, Medsir, Novartis, OncLive, Servier and Telix Pharmaceuticals, and research funding from Novocure and Telix Pharmaceuticals. Louisa von Baumgarten: No disclosures. Stephan Schoenecker: No disclosures. Joerg-Christian Tonn has received honoraria for consultation from, CarThera, ERCM, and Impatients Florian Ringel: No disclosures. Patrick N. Harter No disclosures. Philipp Karschnia: No disclosures.
